Fig. 2.
Drugs characteristics: tumour type (a), number of indication (b), administration mode (c), pharmacological class (d). Note: Data reported for 31 drugs indicated in solid tumours having centralized EU authorisation, 2009-2014. *1 drug targeting 3 types of cancer and 1 drug targeting 2 types of cancer